These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 11030486

  • 1. Mirtazapine compared with paroxetine in major depression.
    Benkert O, Szegedi A, Kohnen R.
    J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
    [Abstract] [Full Text] [Related]

  • 2. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
    Schatzberg AF, Kremer C, Rodrigues HE, Murphy GM, Mirtazapine vs. Paroxetine Study Group.
    Am J Geriatr Psychiatry; 2002 Sep; 10(5):541-50. PubMed ID: 12213688
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E, Skarstein J, Behnke K, Agren H, Helsdingen JT.
    Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
    [Abstract] [Full Text] [Related]

  • 4. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
    Guelfi JD, Ansseau M, Timmerman L, Kørsgaard S, Mirtazapine-Venlafaxine Study Group.
    J Clin Psychopharmacol; 2001 Aug; 21(4):425-31. PubMed ID: 11476127
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A, Crawford GM, Angus M, Wilson R, Hamilton L.
    Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
    [Abstract] [Full Text] [Related]

  • 6. A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.
    Hong CJ, Hu WH, Chen CC, Hsiao CC, Tsai SJ, Ruwe FJ.
    J Clin Psychiatry; 2003 Aug; 64(8):921-6. PubMed ID: 12927007
    [Abstract] [Full Text] [Related]

  • 7. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
    Wheatley DP, van Moffaert M, Timmerman L, Kremer CM.
    J Clin Psychiatry; 1998 Jun; 59(6):306-12. PubMed ID: 9671343
    [Abstract] [Full Text] [Related]

  • 8. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.
    Szegedi A, Müller MJ, Anghelescu I, Klawe C, Kohnen R, Benkert O.
    J Clin Psychiatry; 2003 Apr; 64(4):413-20. PubMed ID: 12716243
    [Abstract] [Full Text] [Related]

  • 9. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, Yi Z, Hong W, Wang Y, Jiang K, Gao K, Cui X, Nierenberg AA, OPERATION Study Team.
    J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
    [Abstract] [Full Text] [Related]

  • 10. Mirtazapine versus selective serotonin reuptake inhibitors.
    Thompson C.
    J Clin Psychiatry; 1999 Aug; 60 Suppl 17():18-22; discussion 46-8. PubMed ID: 10446737
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.
    Fava M, Dunner DL, Greist JH, Preskorn SH, Trivedi MH, Zajecka J, Cohen M.
    J Clin Psychiatry; 2001 Jun; 62(6):413-20. PubMed ID: 11465517
    [Abstract] [Full Text] [Related]

  • 12. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J, Barkin RL.
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.
    Kim JE, Yoon SJ, Kim J, Jung JY, Jeong HS, Cho HB, Shin E, Lyoo IK, Kim TS.
    Int J Clin Pract; 2011 Mar; 65(3):323-9. PubMed ID: 21314870
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
    Versiani M, Moreno R, Ramakers-van Moorsel CJ, Schutte AJ, Comparative Efficacy Antidepressants Study Group.
    CNS Drugs; 2005 Mar; 19(2):137-46. PubMed ID: 15697327
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
    Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.
    J Clin Psychiatry; 2004 Oct; 65(10):1356-64. PubMed ID: 15491239
    [Abstract] [Full Text] [Related]

  • 16. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD.
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [Abstract] [Full Text] [Related]

  • 17. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
    van Moffaert M, de Wilde J, Vereecken A, Dierick M, Evrard JL, Wilmotte J, Mendlewicz J.
    Int Clin Psychopharmacol; 1995 Mar; 10(1):3-9. PubMed ID: 7622801
    [Abstract] [Full Text] [Related]

  • 18. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.
    Roose SP, Nelson JC, Salzman C, Hollander SB, Rodrigues H, Mirtazapine in the Nursing Home Study Group.
    Curr Med Res Opin; 2003 Mar; 19(8):737-46. PubMed ID: 14687445
    [Abstract] [Full Text] [Related]

  • 19. Double-blind study of mirtazapine and placebo in hospitalized patients with major depression.
    Vartiainen H, Leinonen E.
    Eur Neuropsychopharmacol; 1994 Jun; 4(2):145-50. PubMed ID: 7919944
    [Abstract] [Full Text] [Related]

  • 20. Paroxetine versus placebo: a double-blind comparison in depressed patients.
    Claghorn JL, Kiev A, Rickels K, Smith WT, Dunbar GC.
    J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.